Wen Chen Yeh
Technik-/Wissenschafts-/F&E-Leiter bei Surrozen Operating, Inc.
Aktive Positionen von Wen Chen Yeh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2016 | - |
Karriereverlauf von Wen Chen Yeh
Ehemalige bekannte Positionen von Wen Chen Yeh
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SURROZEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2016 | 31.07.2023 |
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2006 | 01.04.2016 |
| University of Toronto | Corporate Officer/Principal | - | - |
Ausbildung von Wen Chen Yeh
| National Taiwan University | Doctorate Degree |
| The Johns Hopkins University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 2 |
| Taiwan | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SURROZEN, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Wen Chen Yeh
- Erfahrung
